MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

Ilamycin C induces apoptosis and inhibits migration and invasion

Izalontamab (SI-B001) is a Bispecific Anti-EGFR/HER3 mAb for Cancer Research

MPT0B014, a Tubulin Polymerization Inhibitor Induces Cancer Cell Apoptosis

RETRACTED ARTICLE: A new synthetic derivative of cryptotanshinone

Cancers, Free Full-Text

MPT0E028, an Orally Active HDAC Inhibitor, Induces Apoptosis by Targeting HDAC and Akt

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

Blogs MedChemExpress

Lexatumumab (HGS 1018) is a TRAIL-R2 Agonist Antibody

MS8815 is a EZH2 PROTAC Degrader for Targeting Triple-Negative

Triple-Negative Breast Cancer - Network of Cancer Research

TTK promotes mesenchymal signaling via multiple mechanisms in

Frontiers Eupalinolide J Suppresses the Growth of Triple

SG-094 is a Potent TPC2 Inhibitor for HCC Reasearch